Medicare Enrolled
Dr. Roel Querubin, M.D.
Rheumatology · Marietta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Querubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Querubin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Querubin
Dr. Roel Querubin is a rheumatology specialist in Marietta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Querubin performed 3,633 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Querubin received a total of $23,817 from 50 pharmaceutical and/or device companies across 1315 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Querubin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 41% volume in GA
$23,817 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,633
Medicare services
Top 41% in GA for rheumatology
Not available
Unique patients (not deduplicated)
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,040 | $18 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
411 | $91 | $246 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
164 | $27 | $102 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
153 | $0 | $20 |
| X-ray of foot, 2 views An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints. |
128 | $21 | $104 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
107 | $11 | $40 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
87 | $50 | $300 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
71 | $26 | $95 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
67 | $96 | $600 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $70 | $180 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
66 | $8 | $14 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
66 | $26 | $110 |
| X-ray of upper spine, 4-5 views An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area. |
47 | $42 | $130 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
43 | $26 | $118 |
| X-ray of sacroiliac joint, 3 or more views An X-ray imaging test that takes three or more pictures of the joint connecting the lower spine to the hip bone. |
41 | $31 | $140 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
31 | $30 | $142 |
| X-ray of both knees, standing An X-ray image of both knees taken while the patient is standing to assess bone alignment and joint space under weight-bearing conditions. |
29 | $28 | $106 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $134 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.5% high complexity
59.1% medium
32.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,817
Total received (2018-2024)
Avg $3,402/year across 7 years
Top 11% in GA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,315
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,649
2023
$4,243
2022
$3,071
2021
$2,251
2020
$1,937
2019
$3,765
2018
$3,900
Payments by company (2024)
Janssen Biotech, Inc.
$1,004
Amgen Inc.
$742
ABBVIE INC.
$666
ANI Pharmaceuticals, Inc.
$543
Novartis Pharmaceuticals Corporation
$350
UCB, Inc.
$223
GlaxoSmithKline, LLC.
$215
PFIZER INC.
$145
AstraZeneca Pharmaceuticals LP
$144
Mallinckrodt Hospital Products Inc.
$144
Lilly USA, LLC
$114
Aurinia Pharma U.S., Inc.
$85
E.R. Squibb & Sons, L.L.C.
$76
Genentech USA, Inc.
$57
Sandoz Inc.
$34
Radius Health, Inc.
$32
Organon Llc
$22
Abbott Laboratories
$19
SOBI, INC
$19
Actelion Pharmaceuticals US, Inc.
$15
Top 3 companies account for 51.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,646
Janssen Biotech, Inc.
$2,251
ABBVIE INC.
$2,217
Novartis Pharmaceuticals Corporation
$2,084
UCB, Inc.
$1,765
PFIZER INC.
$1,503
AbbVie, Inc.
$1,276
Lilly USA, LLC
$1,160
AbbVie Inc.
$829
E.R. Squibb & Sons, L.L.C.
$750
Genentech USA, Inc.
$624
ANI Pharmaceuticals, Inc.
$620
Mallinckrodt Hospital Products Inc.
$617
Horizon Therapeutics plc
$580
GlaxoSmithKline, LLC.
$555
DePuy Synthes Sales Inc.
$420
Radius Health, Inc.
$406
AstraZeneca Pharmaceuticals LP
$366
SANOFI-AVENTIS U.S. LLC
$290
Aurinia Pharma U.S., Inc.
$273
GENZYME CORPORATION
$237
Antares Pharma, Inc.
$198
Mallinckrodt LLC
$187
Boehringer Ingelheim Pharmaceuticals, Inc.
$157
MEDEXUS PHARMA, INC.
$91
Arcutis Biotherapeutics, Inc.
$82
Horizon Pharma plc
$81
Celgene Corporation
$73
Sandoz Inc.
$51
Ultragenyx Pharmaceutical Inc.
$43
Merck Sharp & Dohme Corporation
$34
Organon LLC
$34
Mallinckrodt Enterprises LLC
$27
Organon Llc
$22
Abbott Laboratories
$19
SOBI, INC
$19
Zyla Life Sciences
$19
Alexion Pharmaceuticals, Inc.
$19
Octapharma USA, Inc.
$19
Zimmer Biomet Holdings, Inc.
$19
Fidia Pharma USA Inc.
$18
Ferring Pharmaceuticals Inc.
$18
Mylan Institutional Inc.
$18
Orthogenrx Inc.
$17
Ironwood Pharmaceuticals, Inc
$16
Gilead Sciences, Inc.
$15
Actelion Pharmaceuticals US, Inc.
$15
Kiniksa Pharmaceuticals, Ltd.
$14
Sobi, Inc
$12
West-Ward Pharmaceuticals
$12
Top 3 companies account for 34.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CRYSVITA · Cimzia · DUEXIS · DUZALLO · EUFLEXXA · EVENITY · Enbrel · FORTEO · GenVisc 850 · HUMIRA · HYMOVIS · HYRIMOZ · Humira · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PENNSAID · PROCLAIM · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · Sports Medicine Product Portfolio · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tymlos · XELJANZ · XYOSTED
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
74
County median income
$98,712
Nearest hospital to ZIP centroid (approximate)
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Querubin is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Querubin experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Querubin performed 2,040 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Querubin receive payments from pharmaceutical companies?
Yes. Dr. Querubin received a total of $23,817 from 50 companies across 1,315 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Querubin's costs compare to other rheumatologists in Marietta?
Dr. Querubin's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Querubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Marietta
Browse rheumatologists in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in GA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in GA
Which GA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology